|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,585 JPY | +1.41% |
|
+4.82% | +16.02% |
| Mar. 20 | Kissei Pharmaceutical Completes 6 Billion Yen Buyback Program | MT |
| Mar. 19 | Tranche Update on Kissei Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 8, 2023. | CI |
Kissei Pharmaceutical Co., Ltd. provided consolidated earnings guidance for the fiscal year ending March 31, 2024. For the year, the company expected Net Sales of JPY 77,500 million. Operating profit of JPY 5,000 million.
Profit attributable to owners of parent of JPY 10,000 million. Basic earnings per share of JPY 226.68.
| 1st Jan change | Capi. | |
|---|---|---|
| +16.02% | 1.01B | |
| +5.31% | 70.44B | |
| +10.97% | 8.94B | |
| -16.83% | 4.75B | |
| +43.48% | 4.5B | |
| +3.20% | 3.85B | |
| +18.82% | 2.38B | |
| -21.36% | 2.34B | |
| -29.67% | 2.2B | |
| +8.38% | 1.96B |
KISSEI PHARMACEUTICAL CO., LTD. 
